Zolpidem abuse and dependance;Abus et dependance au zolpidem: A propos de sept cas

Encephale

Volumn 25, Issue 6, 1999, Pages 652-657

  Courtet, P ^a   Pignay, V ^a   Castelnau, D ^b   Boulenger, J P ^a  

^a INSERM   (France)

^b LAPEYRONIE HOSPITAL   (France)

Author keywords

Benzodiazepines; GABA A receptor; Molecular genetics; Substance abuse and dependence; Zolpidem

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BENZODIAZEPINE; ZOLPIDEM; HYPNOTIC SEDATIVE AGENT; PYRIDINE DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG ABUSE; DRUG STRUCTURE; EUPHORIA; FEMALE; HUMAN; HYPNOSIS; MALE; MOLECULAR GENETICS; ADDICTION; AGED; CASE REPORT; MIDDLE AGED;

ADULT; AGED; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; PYRIDINES; SUBSTANCE-RELATED DISORDERS;

EID: 0033374101     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. BLOIS R, GAILLARD JM. The effects of zolpidem on characteristics of normal human sleep. In: Sauvannet JP et al., eds. Imidazopyridines in sleep disorders. New York : Raven Press 1988 : 375-6.
2. BOTTLENDER R, SCHUTZ C, MOLLER MJ et al. Zolpidem dependence in a patient with former polysubstance abuse. Pharmacopsychiatry 1997 ; 30 (3) : 108.
3. 2-aminobutyric acid A receptor affecting modulation of the channel by ligands of the benzodiazepine binding site. Mol Pharmacol 1996 ; 49 : 1080-4.
4. 2 GABA-A receptor drastically alter the affinity for ligands of the benzodiazepine binding site. J Biol Chem 1997a ; 272 (18) : 11799-804.
5. 1 subunit of γ-aminobutyric acid A receptor influence affinities for benzodiazepine binding site ligands. Mol Pharmacol 1997b ; 52 : 676-82.
6. 2 subunit of γ-aminobutyric acid A receptor results in altered benzodiazepine binding site specificity. Proc Nat Acad Sci USA 1997 ; 94 : 8824-9.
7. CAVALLARO R, REGAZZETTI MG, COVELLI G et al. Tolerance and withdrawal with zolpidem. Lancet 1993 ; 342 (8867) : 374-5.
8. EVANS SM, FUNDERBURCK FR, GRIFFITHS RR. Zolpidem and triazolam in humans : behavioral and subjective effects and abuse liability. J Pharmacol Exp Ther 1990 ; 255 (3) : 1246-55.
9. GARCIA LC, MOLINA MM. Dependencia de zolpidem. Medicina Clinica 1996 ; 106 (12) : 478-9.
10. GERICKE CA, LUDOLPH AC. Chronic abuse of zolpidem. JAMA 1994 ; 272 (22) : 1721-2.
11. GRIFFITHS R, SANNERUD CA, ATOR NA et al. Zolpidem behavioral pharmacology in baboons : self-injection, discrimination, tolerance and withdrawal. J Pharmacol Exp Ther 1992 ; 260 : 1199-208.
12. LANGER SZ, ARBILLA S. Limitations of the benzodiazepines receptors nomenclature : a proposal for a pharmacological classification as omega receptor subtype. Fund Clin Pharmacol 1998 ; 2 : 159-70.
13. LANGTRY HD, BENFIELD P. Zolpidem, a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 1990 ; 40 (2) : 291-313.
14. MONTI JM, ATTALI P, MONTI D et al. Zolpidem and rebound insomnia : a double-blind, controlled polysomnographic study in chronic insomniac patients. Pharmacopsychiatry 1994 ; 27 : 166-75.
15. PIGNAY V. Abus et dépendance au zolpidem. Directeur : Professeur JP Boulenger, Université Montpellier : Mémoire pour le DES de Psychiatrie, 1998.
16. re éd. Paris : PUF, 1989.
17. ROGER M, ATTALI P, COQUELIN JP. Multicenter double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia. Clin Ther 1993 ; 15 : 127-36.
18. RUSH CR, GRIFFITHS RR. Zolpidem, triazolam, and temazepam : behavioral and subject-rated effects in normal volunteers. J Clin Psychopharmacol 1996 ; 16 (2) : 146-56.
19. RUSH CR. Behavioral pharmacology of zolpidem relative to benzodiazepines : a review. Pharmacol Biochem Behav 1998 ; 61 (3) : 253-69.
20. RUSH CR, ARMSTRONG DL, ALI JA et al. Benzodiazepine-receptor ligands in humans : acute performance-impairing, subject-rated and observer-rated effects. J Clin Psychopharmacol 1998 ; 18 (2) : 154-65.
21. SIGEL E, BUHR A. The benzodiazepine binding site of GABA-A receptor. Trends in Pharmacol Sci 1997 ; 18 : 425-9.
22. THOME J, RUCHSOW M, ROSLER M et al. Zolpidem dependence and depression on the elderly. Psychiatric Prax 1995 ; 22 (4) : 165-6.
23. WARE JC, WALSH JK, SCHARF MB et al. Minimal rebound insomnia after treatment with 10 mg zolpidem. Clin Neuropharmacol 1997 ; 20 : 116-25.
24. WEERTS EM, GRECH DM, ATOR MA. Zolpidem physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons. J Pharmacol Exp Ther 1998 ; 285 : 41-53.